References
Abraham G, Shukkur A, Van Der Meulen J, Johny KV. Sublingual nifedipine — a safe and simple therapy for hypertensive emergencies. British Journal of Clinical Practice 40: 478–481, 1986
Abrams J. Nitroglycerin and long acting nitrates in clinical practice. American Journal of Medicine 74: 85–94, 1983
Adams LJ, Antonow DR, McClain CJ, McAllister RG. Effect of ranitidine on bioavailability of nifedipine. Abstract. Gastroenterology 90: 1320, 1986
Abrams J. Nitroglycerin and long acting nitrates in clinical practice. American Journal of Medicine 74: 85–94, 1983
Adams LJ, Antonow DR, McClain CJ, McAllister RG. Effect of ranitidine on bioavailability of nifedipine. Abstract. Gastroenterology 90: 1320, 1986
Al-Furaih TA, McElnay JC, Elhorn JS, Rusk R, Scott MG, et al. Sublingual captopril — a pharmacokinetic and pharmacodynamic evaluation. European Journal of Clinical Pharmacology 40: 393–398, 1991
Armstrong PW, Armstrong JA, Marks GS. Blood level after sublingual nitroglycerin. Circulation 59: 585, 1979
Beckett AH, Triggs EJ. Buccal absorption of basic drugs and its application as an in vivo model of passive drug transfer through lipid membranes. Journal of Pharmacy and Pharmacology 19 (Suppl.): 31S–41S, 1967
Beer N, Gallegos I, Cohen A, Klein N, Sonnenblick E, et al. Efficacy of sublingual nifedipine in the acute treatment of systemic hypertension. Chest 79: 571–574, 1981
Bell MDD, Mishra P, Weldon BD, Murray GR, Calvey TN, et al. Buccal morphine — a new route for analgesia? Lancet 1: 71–73, 1985
Benvenuti C, Botta V, Broggini M, Gamboro V, Lodi F, et al. The pharmacokinetics of clotiazepam after oral and sublingual administration to volunteers. European Journal of Clinical Pharmacology 37: 617–619, 1989
Blackett A, Turner P. Correlation of the partition coefficient with the fragment constant f1 and the relationship of f to buccal absorption. British Journal of Clinical Pharmacology 27: 123P, 1989
Blair JSG. Phenazocine hydrobromide BPC in the management of incurable malignant disease. British Journal of Clinical Practice 21: 124–126, 1967
Bogaert MG. Clinical pharmacokinetics of organic nitrates. Clinical Pharmacokinetics 8: 410–421, 1983
Boyle CA, Barry H, Fox E, McCreary C, Bewley A. Controlled comparison of a new sublingual lormetazepam formulation and IV diazepam in outpatient minor oral surgery. British Journal of Anaesthesia 60: 419–425, 1988
Brown AS. Absorption of analgesics from the buccal mucous membrane. Practitioner 196: 125–126, 1966
Bullingham RES, McQuay HJ, Porter EJB, Allen MC, Moore RA. Sublingual buprenorphine used post-operatively: ten hour plasma drug concentration analysis. British Journal of Clinical Pharmacology 13: 665–673, 1982
Bussman W-D, Kromm W, Reifart N, Fung H-L. Acute haemodynamic and pharmacokinetic effects of buccal nitroglycerin. In Advances in pharmacotherapy, Vol. 1, pp. 64–72, Karger, Basel, 1982
Davis SS, Kennerley JW, Taylor MJ, Hardy JG, Wilson CG. Scintigraphic studies on the in vivo dissolution of a buccal tablet. In Goldberg & Parsons (Eds). Modern concepts in nitrate delivery systems, Royal Society of Medicine, London, 1983
De Boer AG, de Leede LGJ, Breimer DD. Drug absorption by sublingual and rectal routes. British Journal of Anaesthesia 56: 69–82, 1984
Deenstra M, Haalboom JRE, Strugvenberg A. Decrease of plasma potassium due to inhalation of beta2 agonists: absence of an additional effect of intravenous theophylline. European Journal of Clinical Investigation 18: 162–165, 1988
Derbyshire DR, Vater M, Maile CID. Non-parenteral post-operative analgesia: a comparison of sublingual buprenorphine and morphine sulfate (slow release) tablets. Anaesthesia 39: 324–328, 1984
Dessi-Fulgheri P, Bandiera F, Rubattu S, Cocco F, Madeddu P, et al. Comparison of sublingual and oral captopril in hypertension. Clinical and Experimental Hypertension. Part A — Theory and Practice. A9 593–597, 1987
Dewland PM, Tanner T, Woodward AJ. Study of bioavailabilities of glyceryl trinitrate spray formulations as a basis for equivalent dosaging in cardiac emergency. Herz und Gefabe: Zeitschrift für Praktische Kardioangiologie 13: 3–7, 1987
Edge WG, Cooper GM, Morgan M. Analgesic effects of sublingual buprenorphine. Anaesthesia 34: 463–467, 1979
Editorial. Administration of drugs by the buccal route. Lancet 1: 666–667, 1987
Ellrodt AG, Ault MJ, Riedinger MS, Murata GH. Efficacy and safety of sublingual nifedipine in hypertensive emergencies. American Journal of Medicine 79 (Suppl. 4A): 19–25, 1985
Fisher AP, Fung C, Hanna M. Serum morphine concentrations after buccal and intramuscular morphine administration. British Journal of Clinical Pharmacology 24: 685–687, 1987
Fitzpatrick MA, Julius S. Haemodynamic effects of angiotensinconverting enzyme inhibitors in essential hypertension: a review. Journal of Cardiovascular Pharmacology 7 (Suppl. 1) 35–9, 1985
Fry ENS. Relief of pain after surgery: a comparison of sublingual buprenorphine and intramuscular papaveretum. Anaesthesia 34: 549–551, 1979
Greenblatt DJ, Divoll M, Harmatz JS, Shader RI. Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular and oral lorazepam. Journal of Pharmaceutical Sciences 71: 248–252, 1982
Guerrera G, Melina D, Capaldi L, Tatulli C, Savi L, et al. Usefulness of sublingual captopril in hypertensive crises. Abstract 1070. International Society for Hypertension in Kyoto, Abstract Book, 1989
Haude M, Steffen W, Erbel R, Tschollar W, Belz GG, et al. Haemodynamics after sublingual administration of captopril in severe heart failure. Deutsche Medizinische Wochenschrift 114: 1095–1100, 1989
Haude M, Steffen W, Pop T, Tschollar W, Meyer J. Sublingual captopril versus nitroglycerine in patients with heart failure — a randomised cross-over study. Abstract 2464. Circulation 78 (Suppl. II): II–618, 1988
Hauger-Klevene JH. Captopril in hypertensive crisis. Lancet 2: 732–733, 1985
Hessen PG, Lloyd Jones JG, Muir NC, Parr GD, Sugden K. A comparison of the availability of prochlorperazine following i.m. buccal and oral administration. International Journal of Pharmaceutics 52: 159–164, 1989
Hopton D. Double-blind clinical trial of the analgesic effects of phenazocine hydrobromide (Narphen) compared with morphine sulphate in patients with acute abdominal pain. Gut 12: 51–54, 1971
Hopton DS, Torrance HB. Action of various new analgesic drugs on the human common bile duct. Gut 8: 296–300, 1967
Jacqmin P, Ansseau M. Comparison of sublingual and oral prazepam in normal subjects II: pharmacokinetic and pharmacodynamic data. Neuropsychobiology 19: 186–191, 1988
Karachalios GN, Chrisikos N, Kintziou H, Petrogiannopoulos K, Kehagioglou K. Treatment of hypertensive crisis with sublingual captopril. Current Therapeutic Research 48: 5–9, 1990
Karachalios GN, Georgiopoulos AN. Treatment of hypertensive crisis with sublingual captopril. Clincal Pharmacology 8: 89–90, 1989
Kimchi A, Lee G, Amsterdam E, Fuji K, Krieg P, et al. Increased exercise tolerance after nitroglycerin oral spray: a new and effective therapeutic modality in angina pectoris. Circulation 67: 124–127, 1983
Kung M, Croley SW, Phillips BA. Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of inhaled albuterol: influence of mouth rinsing and gargling. Chest 91: 382–387, 1987
Lacche A, Basaglia P. Hypertensive emergencies: effects of therapy by nifedipine administered sublingually. Current Therapeutic Research 34: 879–887, 1983
Lahiri A, Bowles MJ, Brigden G, Whittington JR, Duffy SW, et al. Buccal nitroglycerin and intravenous isosorbide dinitrate in unstable angina: a double-blind study of acute administration. American Journal of Noninvasive Cardiology 3: 281–289, 1989
Lederballe Pedersen O, Christensen NJ, Ramsch KD. Comparison of acute effects of nifedipine in normotensive and hypertensive man. Journal of Cardiovascular Pharmacology 2: 357–366, 1980
Lewis JW. Ring C-bridged derivatives of thebaine and oripavine narcotic antagonist. In Brande et al. (Eds) Advances in biological psychopharmacology, Vol. 8, pp. 123–136, Raven Press, New York 1974
Lipworth BJ, Clark RA, Dhillon DP, Moreland TA, Struthers AD, et al. Pharmacokinetics efficacy and adverse effects of sublingual salbutamol in patients with asthma. European Journal of Clinical Pharmacology 37: 567–571, 1989a
Lipworth BJ, McDevitt DG, Struthers AD. Systemic β-adrenoceptor responses to salbutamol given by metered-dose inhaler alone, and with pear-shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects. British Journal of Clinical Pharmacology 27: 837–842, 1989b
Longhini C, Ansani L, Musacci GF, Mele D, Vaccari M, et al. The effect of captopril on peripheral haemodynamics in patients with essential hypertension: comparison between oral and sublingual administration. Cardiovascular Drugs and Therapy 4: 751–754, 1990
Martin AJ, Erben A, Landau LI, Phelan PD. Assessment of buccal mucosa administration of salbutamol aerosol. In Shaw DT (Ed.) Recent advances in aerosol science, pp. 113–116, John Wiley, London, 1976
Mason DT, Zelis R, Amsterdam EA. Actions of the nitrates on the peripheral circulation and myocardial oxygen consumption: significance in the relief of angina pectoris. Chest 59: 296, 1971
McQuay HJ, Moore RA, Bullingham RES. Buprenorphine kinetics. In Foley & Inturrisi (Eds) Advances in pain research and therapy, Vol. 8, pp. 271–283, Raven Press, New York, 1986
Murrell W. Nitroglycerine as a remedy for angina pectoris. Lancet 1: 80–81, 113–115, 151–152, 225–227, 1879
Nussmeier NA, Curling PE, Murphy DA, Guyton RA, Crower JM, et al. Nifedipine: cardiovascular effects after sublingual administration during fentonyl-pancuronium anesthesia in man. Abstract. Anesthesiology 59: A34, 1983
Nyberg G. Onset time of action and duration up to 3 hours of nitroglycerin in buccal, sublingual and transdermal form. European Heart Journal 7: 673–678, 1986
O’Hanrahan M, McGarry K, Kelly JG, Horgan J, O’Malley K. Diminished activity of glyceryl trinitrate. British Medical Journal 284: 1183–1184, 1982
Ohashi K, Turner P. Buccal absorption characteristics of some selective and non-selective beta-adrenoceptor agonists and antagonists. British Journal of Clinical Pharmacology 9: 120P, 1980
Ohman PK, Kagedak B, Larsson R, Karlberg BE. Pharmacokinetics of captopril and its effects on blood pressure during acute and chronic administration and in relation to food intake. Journal of Cardiovascular Pharmacology 7 (Suppl. 1): S20–S24, 1985
Osborne RJ, Joel SP, Trew D, Slevin ML. The analgesic activity of morphine-6-glucuronide. Lancet 1: 828, 1988
Osborne R, Joel SP, Trew D, Slevin M. Morphine and metabolite behaviour after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clinical Pharmacology and Therapeutics 47: 12–19, 1990
Oto A, Cyhan B, Caymaz O, Oram E, Oram A, et al. Sublingual captopril in hypertensive emergencies. Abstract no. P424. European Heart Journal 9 (Abst. Suppl. 1): 75, 1988
Ouellette RD, Mok MS, Gilbert MS. Comparison of buprenorphine and morphine: a multicenter multidose study in patients with severe post-operative pain. Contemporary Surgery 28: 55–59, 62-64, 1986
Parker JO, Vankoughnett KA, Farrell B. Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance in stable angina pectoris. American Journal of Cardiology 56: 724–728, 1985
Parker JO, Vankoughnett KA, Farrell B. Nitroglycerin lingual spray: clinical efficacy and dose-response relation. American Journal of Cardiology 57: 1–5, 1986
Prager G. Buccal synchron nitroglycerin in acute treatment of angina pectoris attacks: a comparison with sublingually administered nitroglycerin in patients with stable coronary artery disease. In Bussmann et al. (Eds) Advances in pharmaco-therapy. Vol. 1, pp. 137–142, Karger, Basel, 1982
Ramsch KD. Zur Pharmacokinetik von Nifedipin. Schwerpunkt Medizinische 4: 55–61, 1981
Rodenstein D, Stanescu DC. Mouth spraying versus inhalation of fenoterol aerosol in healthy subjects and asthmatic patients. British Journal of Diseases of the Chest 76: 365–373, 1982
Russell WS, Badcock NR, Frewin DB, Sanborn LN. Pharmacokinetics of a new sublingual formulation of temazepam. European Journal of Clinical Pharmacology 35: 437–439, 1988
Ryden L, Schaffrath R. Buccal versus sublingual nitroglycerin administration in the treatment of angina pectoris: a multicentre study. European Heart Journal 8: 995–1001, 1987
Sanders SW, Michaelis K, Maurette JM, Jaeger HJ. Relative bioavailability of two spray formulations of nitroglycerin. Journal of Pharmaceutical Sciences 75: 244–246, 1986
Sawe J, Kager L, Svenson Eng JO, Rane A. Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation action. British Journal of Clinical Pharmacology 19: 495–501, 1985
Scavone JM, Greenblatt DJ, Friedman H, Shader RI. Enhanced bioavailability of triazolam following sublingual versus oral administration. Journal of Clinical Pharmacology 26: 208–210, 1986
Scavone JM, Greenblatt DJ, Shader RI. Alprazolam kinetics following sublingual and oral administration. Journal of Clinical Psychopharmacology 7: 332–334, 1987
Schor JM, Davis SS, Nigalaye A, Bolton S. Susadrin transmucosal tablets (nitroglycerin in Synchron® controlled-release base). Drug Development and Industrial Pharmacy 9: 1359–1377, 1983
Schuman S, Herxheimer H. The bronchodilator action of salbutamol in asthmatics. Postgraduate Medical Journal 47 (Suppl.): 92–99, 1971
Shore SC, Weinberg EG, Dur MH. Buccal administration of fenoterol aerosol in young children with asthma. South African Medical Journal 50: 1362–1364, 1976
Sobrero A. Sur pluriers composés detonants practu avec l’acide nitrique et le sucre, la dextrine, la lactine, la mannite et la glycerine. Comptes Rendus Hebdomadaires des Séances de l’Académie des Sciences 24: 247–248, 1847
Sorkin EM, Clissold SP, Brogden RN. Nifedipine — a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in ischaemic heart disease, hypertension and related cardiovascular disorders. Drugs 30: 182–274, 1985
Taburet AM, Singlas E, Colin JN, Banzet O, Thibonnier M. Pharmacokinetic studies of nifedipine tablet: correlation with antihypertensive effects. Hypertension 5 (Suppl. II): II29–II33, 1983
Tauber U, Tack JW, Doron R, Hilman J. Plasma levels of lormetazepam after sublingual and oral administration of 1 mg to humans. Drug Development and Industrial Pharmacy 10: 1587–1596, 1984
Tayhlor WB, Bateman DN. Preliminary studies of the pharmacokinetics and pharmacodynamics of prochlorperazine in healthy volunteers. British Journal of Clinical Pharmacology 23: 137–142, 1987
Thomas P, Reilly P, Worsley GH, Roberts RS. Airways responses in patients with stable asthma to oropharyngeal, intranasal and inhaled doses of a beta agonist. Abstract 473. American Reivew of Respiratory Disease 141 (Suppl.): A473, 1990
Thompson DG, Richelson E, Malagelada JR. Perturbation of gastric emptying and duodenal motility via the central nervous system. Gastroenterology 83: 1200–1206, 1982
Traube M, Hongo H, McAllister RG, McCallum RW. Correlation of plasma levels of nifedipine and cardiovascular effects after sublingual dosing in normal subjects. Journal of Clinical Pharmacology 25: 125–129, 1985
Tschollar W, Belz GG. Sublingual captopril in hypertensive crisis. Lancet 2: 732–733, 1985
Van Harten J, Burggraaf K, Danhof M, van Brummelen P, Breimer DD. Negligible sublingual absorption of nifedipine. Lancet 2: 1363–1365, 1987
Wampler G. The pharmacology and clinical effectiveness of phenothiazines and related drugs for managing chemotherapy-induced emesis. Drugs 25 (Suppl. 1): 35–51, 1983
Ward AE. Studies of prochlorperazine as a buccal tablet (Buccastem) and an oral tablet (Stemetil) for the treatment of dizziness, nausea or vomiting in a general practice setting. British Journal of Clinical Practice 42: 228–232, 1988
Weinberg DS, Inturissi CE, Reidenberg B, Moulin DE, Nip TU, et al. Sublingual absorption of selected opioid analgesics. Clinical Pharmacology and Therapeutics 44: 335–342, 1988
Wight LW, Potter CE, Vandenburg MJ, Brandman S. Experience with Nitrolingual Spray in general practice. British Journal of Clinical Practice 44: 55–57, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Motwani, J.G., Lipworth, B.J. Clinical Pharmacokinetics of Drugs Administered Buccally and Sublingually. Clin. Pharmacokinet. 21, 83–94 (1991). https://doi.org/10.2165/00003088-199121020-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199121020-00001